Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open

[Image: see text]

Detalles Bibliográficos
Autores principales: Panaccione, Remo, Abreu, Maria T., Lazariciu, Irina, Mundayat, Rajiv, Lawendy, Nervin, Salese, Leonardo, Woolcott, John C., Sands, Bruce E., Chaparro, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Tofacitinib in Ulcerative Colitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311428/
https://www.ncbi.nlm.nih.gov/pubmed/35246988
http://dx.doi.org/10.1111/apt.16848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311428/
https://www.ncbi.nlm.nih.gov/pubmed/35246988
http://dx.doi.org/10.1111/apt.16848

Ejemplares similares